DermaSensor
FL - MiamiBiotechnology
Focus: DermaSensor develops non-invasive skin cancer diagnostic devices using elastic scattering spectroscopy technology. The company operates in the specialized oncology/dermatology diagnostic space with a focus on melanoma and skin cancer assessment.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About DermaSensor
AI assessmentNot HiringNo open roles listed right now. Follow DermaSensor to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Lesion biopsy
Skin CancerClinical Trials (1)
NCT06690086DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer
N/AHelp build intelligence for DermaSensor
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.